Clinical trial
The Safety and Efficacy of Drug Eluting Peripheral Vascular Stent System for the Treatment of Superficial Femoral Artery Stenosis and /or Occlusion: a Multi-center Stratified Randomized Single- Blind Controlled Trial
NCT03121430 is registered in ClinicalTrials.gov with Zhejiang Zylox Medical Device Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Safety and Efficacy of Drug Eluting Peripheral Vascular Stent System for the Treatment of Superficial Femoral Artery Stenosis and /or Occlusion: a Multi-center Stratified Randomized Single- Blind Controlled Trial
- Lead sponsor
- Zhejiang Zylox Medical Device Co., Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 22, 2018
- Completion date
- February 28, 2021
- Enrollment
- 138 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
peripheral arterial disease, superficial femoral artery occlusion, superficial femoral artery stenosis